Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10000970 | 1.00 | LTA4H (0.34) | LTA4HTP53NPY5RSMN1; SMN2 | |
| SCHEMBL13033875 | 0.81 | ALDH1A1 (0.35) | NPY5RSMN1; SMN2 | |
| SCHEMBL8386456 | 0.79 | CHRNB2 (0.31) | — | |
| SCHEMBL8386454 | 0.79 | — | — | |
| SCHEMBL2736118 | 0.79 | — | — | |
| SCHEMBL1983612 | 0.77 | ADAMTS4 (0.33) | TP53SMN1; SMN2 | |
| SCHEMBL755790 | 0.77 | ADAMTS4 (0.33) | TP53SMN1; SMN2 | |
| SCHEMBL6016722 | 0.77 | TGFBR1 (0.34) | LTA4HTP53 | |
| SCHEMBL6016723 | 0.77 | TGFBR1 (0.34) | LTA4HTP53 | |
| SCHEMBL3636117 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2152680-B1 | METHOD FOR PREPARING ENANTIOMERICALLY ENRICHED N-CARBOXYANHYDRIDE | SANOFI SA (FR) | 2015-06-24 | — | — | EP | disclosed |
| US-20120215007-A1 | METHOD FOR PREPARING ENANTIOMERICALLY ENRICHED N-CARBOXYANHYDRIDE | SANOFI (FR) | 2012-08-23 | — | — | US | disclosed |
| US-20120215007-A1 | METHOD FOR PREPARING ENANTIOMERICALLY ENRICHED N-CARBOXYANHYDRIDE | SANOFI (FR) | 2012-08-23 | — | — | US | disclosed |
| US-20120215007-A1 | METHOD FOR PREPARING ENANTIOMERICALLY ENRICHED N-CARBOXYANHYDRIDE | SANOFI (FR) | 2012-08-23 | — | — | US | disclosed |
| US-8119813-B2 | Method for preparing enantiomerically enriched N-carboxyanhydride | SANOFI-AVENTIS (FR) | 2012-02-21 | — | — | US | disclosed |
| US-8119813-B2 | Method for preparing enantiomerically enriched N-carboxyanhydride | SANOFI-AVENTIS (FR) | 2012-02-21 | — | — | US | disclosed |
| US-8119813-B2 | Method for preparing enantiomerically enriched N-carboxyanhydride | SANOFI-AVENTIS (FR) | 2012-02-21 | — | — | US | disclosed |
| WO-2011091532-A1 | HEPATITIS C INHIBITOR COMPOUNDS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2011-08-04 | — | — | WO | disclosed |
| US-20100113797-A1 | METHOD FOR PREPARING ENANTIOMERICALLY ENRICHED N-CARBOXYANHYDRIDE | SANOFI-AVENTIS (FR) | 2010-05-06 | — | — | US | disclosed |
| US-20100113797-A1 | METHOD FOR PREPARING ENANTIOMERICALLY ENRICHED N-CARBOXYANHYDRIDE | SANOFI-AVENTIS (FR) | 2010-05-06 | — | — | US | disclosed |
| US-20100113797-A1 | METHOD FOR PREPARING ENANTIOMERICALLY ENRICHED N-CARBOXYANHYDRIDE | SANOFI-AVENTIS (FR) | 2010-05-06 | — | — | US | disclosed |
| WO-2009004141-A2 | METHOD FOR PREPARING ENANTIOMERICALLY ENRICHED N-CARBOXYANHYDRIDE | SANOFI-AVENTIS (FR) | 2009-01-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120215007-A1 | METHOD FOR PREPARING ENANTIOMERICALLY ENRICHED N-CARBOXYANHYDRIDE | DNPEP, NPPA, CPN1 | LTA4H 2882/4885TP53 2364/4885NPY5R 511/4885 |
| US-20100113797-A1 | METHOD FOR PREPARING ENANTIOMERICALLY ENRICHED N-CARBOXYANHYDRIDE | DNPEP, NPPA, CPN1 | LTA4H 2882/4885TP53 2364/4885NPY5R 511/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.